Medplus Health Services informs about order from drugs and control authority

29 Nov 2023 Evaluate
Pursuant to Regulation 30, read with Clause 20 Para A of Part A of Schedule III, of SEBI Listing Regulations, Medplus Health Services has informed that one of its Subsidiary Company has received an order from Drugs and Control Authority. The detailed disclosure with respect to the order as required under the SEBI Circular SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated 13 July 2023 is enclosed herewith as per Annexure A. The aforesaid information is also being placed on the website of the Company at www.medplusindia.com

The above information is a part of company’s filings submitted to BSE.

Medplus Health Servi Share Price

754.05 10.35 (1.39%)
28-Mar-2025 09:53 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1735.45
Dr. Reddys Lab 1144.05
Cipla 1441.70
Lupin 2026.50
Zydus Lifesciences 885.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...